These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 29878238

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 3. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G, Van der Auwera G, Giot JB, Hayette MP, Tassin F, Arrese Estrada J, Cnops L, Moutschen M, de Leval L, Leonard P.
    BMC Infect Dis; 2017 Jul 07; 17(1):478. PubMed ID: 28687071
    [Abstract] [Full Text] [Related]

  • 6. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A, Joseph M, Feltis T, Morris SK.
    Am J Trop Med Hyg; 2016 Oct 05; 95(4):793-794. PubMed ID: 27549634
    [Abstract] [Full Text] [Related]

  • 7. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
    Asilian A, Jalayer T, Nilforooshzadeh M, Ghassemi RL, Peto R, Wayling S, Olliaro P, Modabber F.
    Bull World Health Organ; 2003 Oct 05; 81(5):353-9. PubMed ID: 12856053
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J, Bazarsky E, Sneir R.
    Exp Parasitol; 2007 Jun 05; 116(2):156-62. PubMed ID: 17306255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cutaneous leishmaniasis treatment.
    Minodier P, Parola P.
    Travel Med Infect Dis; 2007 May 05; 5(3):150-8. PubMed ID: 17448941
    [Abstract] [Full Text] [Related]

  • 12. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 May 05; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous leishmaniasis in the returning traveler.
    Magill AJ.
    Infect Dis Clin North Am; 2005 Mar 05; 19(1):241-66, x-xi. PubMed ID: 15701556
    [Abstract] [Full Text] [Related]

  • 14. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1.
    Zur E.
    Int J Pharm Compd; 2019 Mar 05; 23(3):200-207. PubMed ID: 31085788
    [Abstract] [Full Text] [Related]

  • 15. Occlusive paromomycin for cutaneous leishmaniasis.
    Bell SA, Schaller M, Röcken M.
    Lancet; 1997 Jan 04; 349(9044):29. PubMed ID: 8988124
    [No Abstract] [Full Text] [Related]

  • 16. Occlusive paromomycin for cutaneous leishmaniasis.
    Bryceson AD.
    Lancet; 1997 May 17; 349(9063):1477. PubMed ID: 9164342
    [No Abstract] [Full Text] [Related]

  • 17. [American cutaneous leishmaniasis: special features in diagnosis and therapy].
    Bormann G, William T, Schulz A, Marsch W, Gaber G.
    Dtsch Med Wochenschr; 2003 Oct 02; 128(40):2065-8. PubMed ID: 14523685
    [Abstract] [Full Text] [Related]

  • 18. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A, Ben Messaoud N, Guedri E, Zaatour A, Ben Alaya N, Bettaieb J, Gharbi A, Belhadj Hamida N, Boukthir A, Chlif S, Abdelhamid K, El Ahmadi Z, Louzir H, Mokni M, Morizot G, Buffet P, Smith PL, Kopydlowski KM, Kreishman-Deitrick M, Smith KS, Nielsen CJ, Ullman DR, Norwood JA, Thorne GD, McCarthy WF, Adams RC, Rice RM, Tang D, Berman J, Ransom J, Magill AJ, Grogl M.
    N Engl J Med; 2013 Feb 07; 368(6):524-32. PubMed ID: 23388004
    [Abstract] [Full Text] [Related]

  • 19. [Leishmaniasis : Diagnosis and therapy].
    von Stebut E.
    Hautarzt; 2017 Jul 07; 68(7):548-552. PubMed ID: 28597032
    [Abstract] [Full Text] [Related]

  • 20. [CUTANEOUS LEISHMANIASIS IN ISRAEL 2016 - AN UPDATE].
    Solomon M, Schwartz E.
    Harefuah; 2016 Oct 07; 155(10):626-631. PubMed ID: 28530056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.